Ixico PLC - London-based neuroscience data analytics company - Says it has extended a contract originally signed in April 2019. The existing client will use Ixico's services on its phase I/II trial into Huntington's disease. The contract extension is worth around GBP800,000, which Ixico expects to deliver across a four-year period. Read More
Ixico PLC - London-based medical imaging company - Posts lower interim profit for the half year ended March 31. Pretax profit falls to GBP201,000 from GBP635,000 a year ago due to the impact of cancelled client trials. Revenue drops to GBP3.9 million from GBP4.9 million. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - IXICO PLC said Thursday Chief Financial Officer Grant Nash has joined the board of the neuroscience-focused data analytics firm, whilst Non-Executive Director Tim Sharpington to Read More
(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------J up 3.8%. The is Read More
